Jasper Therapeutics, Inc. (JSPR)
Nasdaq: JSPR · Biological Products, (No Diagnostic Substances) · Redwood City, CA · filing with the SEC since 2019
Who owns Jasper Therapeutics, Inc.
As filed with the SECHolders of 5% or more
3
Velan Capital Investment Management LP holds 9.9% of Voting Common Stock, par value $0.0001 per share, as its SCHEDULE 13G filed Aug 17, 2026 says.
Directors and officers
14
report now, of 26 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Velan Capital Investment Management LP
SCHEDULE 13G · filed Aug 17, 2026 · Voting Common Stock, par value $0.0001 per share · 9.88% in Jul 20, 2026
T. Rowe Price Investment Management, Inc.
SCHEDULE 13G · filed Nov 14, 2025 · COMMON STOCK
Anders Hove
SCHEDULE 13G/A · filed Jan 26, 2026 · Common Stock, $0.001 Par Value · 6.4% in Dec 2, 2025
Morgan Stanley
SCHEDULE 13G/A · filed May 12, 2026 · Voting Common Stock · reported falling below 5%, from 7% in Feb 11, 2026
Kingdon Capital Management, L.L.C.
SCHEDULE 13G/A · filed Nov 12, 2025 · Voting Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.1% in Jul 11, 2025
The Carlyle Group Inc.
SCHEDULE 13D/A · filed Feb 18, 2026 · Voting Common Stock, par value $0.0001 per share · reported falling below 5%
Qiming U.S. Healthcare Fund II, L.P.
SCHEDULE 13G/A · filed Nov 14, 2025 · Voting Common Stock, par value $0.0001 · reported falling below 5%
Integrated Core Strategies (US) LLC
SCHEDULE 13G/A · filed Jul 10, 2026 · Voting Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.8% in Feb 25, 2026
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 17, 2025 · Common Stock · reported falling below 5%
Soleus Capital Management, L.P.
SCHEDULE 13G/A · filed May 8, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 9.96% in Feb 11, 2025
Goldman Sachs Group Inc.
SCHEDULE 13G/A · filed May 8, 2026 · Voting Common Stock, par value $0.0001 per share · reported falling below 5%, from 6.3% in Feb 12, 2026
What JSPR reports owning in othersstakes of 5% or more, and other ties
Jasper Therapeutics, Inc. reports no stake in another company in the record.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.